Omeed Moaven

15PUBLICATIONS
28CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 03, 2026
Integrative Proteomic Analysis Reveals VMG Oncolytic Virus-Induced Molecular Reprogramming in Pancreatic Ductal Adenocarcinoma.

|Mar 27, 2026
Comparative Proteomic Profiling of Responses to Standard Systemic Treatment Regimens in Pancreatic Cancer.

Amirsalar Mansouri, Olivia Hart, Sina Aslanabadi

|Jan 19, 2026
Does Prophylactic Intraperitoneal Chemotherapy Provide Any Clinical Benefit After Curative Colorectal Cancer Resection?

Omeed Moaven

|Jan 23, 2025
Disparities in Access to Care in the Multimodal Treatment of Primary Nonmetastatic Liver Cancers and Their Impact on Patient Outcomes.

McKenzie Hargis, Denise Danos, Hannah R Malinosky

|Oct 14, 2024
Racial Inequities in Receiving Neoadjuvant Treatment in Patients With Pancreatic Cancer Are Associated With Worse Outcomes in Louisiana.

Hannah R Malinosky, Andrew G Chapple, McKenzie Hargis

|Aug 26, 2024
Prognostic implications of margin status in association with systemic treatment in a cohort study of patients with resection of colorectal liver metastases.

Omeed Moaven, Bigyan B Mainali, Cristian D Valenzuela

Pageof 3

Frequent Collaborators

2 joint publications

Jovanny Zabaleta

2 joint publications

Christopher W Mangieri

2 joint publications

John A Stauffer

2 joint publications

Mitesh J Borad